SESSION TITLE: Asthma Posters II
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 29, 2014 at 01:30 PM - 02:30 PM
PURPOSE: International guidelines dictate goals for optimizing asthma management. In real life, there is a gap between treatment regimens and asthma guidelines in how physicians deal with sub-optimal asthma control. Misperceptions on the level of asthma control both from physicians and patients’ perspectives partially explain this gap. The aim of this prospective study is to compare asthma control status in real life determined by asthma control tools, and primary care and chest physicians’ opinions.
METHODS: 50 Physicians randomly chosen (25 primary care and 25 chest specialists) were asked to enroll all their asthmatic patients encountered in the timeframe of one month of a spring season. Data collected looked on patients’ demographics and asthma types. Asthma tools (Asthma control test (ACT)) and GINA guidelines) and physicians perceptions of patient control were recorded.
RESULTS: 746 asthmatic patients (55.3% female) were listed. 517 patients (69.3%) had an age between 20-60 years old. 39% of the asthma visits were unscheduled and 89% of the visits were outpatients. Perennial asthma and pulmonary function tests reversibility were 54.8% and 44.6% respectively. 34% of the patients were smokers. Uncontrolled asthma was detected in 64% and 76% by chest and primary care physician’s opinions respectively. ACT scores and GINA guidelines detected uncontrolled asthma in 65% and 72% respectively.
CONCLUSIONS: Two third of asthmatic patients had uncontrolled asthma control. Organized medical records applied by physicians and asthma control tools are both effective in determining control.
CLINICAL IMPLICATIONS: Chest physicians’ opinions were closely correlated with ACT results whereas primary care physicians’ opinions were closer to GINA guidelines.
DISCLOSURE: The following authors have nothing to disclose: Moussa Riachy, Georges Juvelikian, Marie Louise Koussa, Nadim Kanj
No Product/Research Disclosure Information